| Literature DB >> 24885561 |
Lixing Zhuang, Jun He1, Xun Zhuang, Liming Lu.
Abstract
BACKGROUND: Results from clinical studies on acupuncture for stroke rehabilitation are contradictory. The reason for the inconsistent findings especially lie in the transparency and accuracy of randomized controlled trials (RCTs) reports. This study aims to analyze the quality of reporting and its correlates in RCTs on acupuncture for stroke rehabilitation.Entities:
Mesh:
Year: 2014 PMID: 24885561 PMCID: PMC4030573 DOI: 10.1186/1472-6882-14-151
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Overall quality of reporting rating using items from the CONSORT Statement (n = 15)
| 1 | “Randomized” in the title or abstract | Study identified as a randomized controlled in the title or abstract | 15 | 100 | - | 1.00 | - |
| 2 | Background | Adequate description of the scientific background and explanation of rationale | 12 | 80 | 57 to 100 | 0.74 | 0.50 to 0.98 |
| 3 | Trial design | Description of trial design (such as parallel, factorial) including allocation ratio | 10 | 67 | 40 to 94 | 0.71 | 0.45 to 1.00 |
| 4 | Participants | Description of the eligibility criteria for participants | 13 | 87 | 67 to 100 | 0.78 | 0.40 to 1.00 |
| 5 | Interventions | Details of the interventions intended for each group | 11 | 73 | 48 to 99 | 0.82 | 0.70 to 1.00 |
| 6 | Outcomes | Definition of primary (and secondary when appropriate) outcome measures | 4 | 27 | 1 to 52 | 0.85 | 0.75 to 0.99 |
| 7 | Sample size | Description of sample size calculation | 2 | 13 | −6 to 33 | 0.83 | 0.68 to 1.00 |
| 8 | Randomization | Description of the method used to generate the random sequence | 9 | 60 | 32 to 88 | 0.76 | 0.60 to 0.99 |
| 12 | Statistical methods | Description of the statistical methods used to compare groups for primary outcomes, subgroup analyses, or adjusted analyses | 11 | 73 | 48 to 99 | 0.73 | 0.40 to 1.00 |
| 13 | Flow chart | Details on the flow of participants through each stage of the trials (No. of patients randomly assigned, receiving intended treatment, completing the protocol and analyzed) | 5 | 33 | 6 to 60 | 0.84 | 0.68 to 1.00 |
| 14 | Recruitment | Dates defining the periods of recruitment and follow-up | 6 | 40 | 12 to 68 | 0.65 | 0.38 to 0.99 |
| 15 | Baseline data | An outline of baseline demographic and clinical characteristics of each group | 14 | 93 | 79 to 100 | 0.68 | 0.42 to 1.00 |
| 17 | Outcomes and estimation | For each primary and secondary outcome, a summary of results for each group is given, and the estimated effect size and its precision (e.g. 95% CI) | 4 | 27 | 1 to 52 | 0.75 | 0.52 to 1.00 |
| 18 | Ancillary analyses | Clear statement of whether subgroup/adjusted analyses were prespecified or exploratory | 3 | 20 | −3 to 43 | 0.68 | 0.35 to 0.99 |
| 19 | Harms | Description of all important adverse events in each group | 5 | 33 | 6 to 60 | 0.85 | 0.72 to 1.00 |
Overall quality of reporting rating using items from STRICTA (n = 15)
| 1 | Acupuncture rationale | (1a) Style of acupuncture (e.g., Traditional Chinese Medicine, Japanese, Korean, Western medical, Five Element, ear acupuncture, etc.) | 12 | 80 | 57 to 100 | 0.65 | 0.38 to 0.98 |
| | | (1b) Reasoning for treatment provided, based on historical context, literature sources and/or consensus methods, with references where appropriate | 12 | 80 | 57 to 100 | 0.78 | 0.60 to 1.00 |
| | | (1c) Extent to which treatment was varied | 10 | 67 | 40 to 94 | 0.72 | 0.48 to 0.95 |
| 2 | Details of needling | (2a) Number of needle insertions per subject per session (mean and range where relevant) | 10 | 67 | 40 to 94 | 0.75 | 0.60 to 0.99 |
| | | (2b) Names (or location if no standard name) of points used (uni-/bilateral) | 12 | 80 | 57 to 100 | 0.83 | 0.65 to 1.00 |
| | | (2c) Depth of insertion, based on a specified unit of measurement or on a particular tissue level | 8 | 53 | 25 to 82 | 0.92 | 0.81 to 1.00 |
| | | (2d) Responses sought (e.g., de qi or muscle twitch response) | 9 | 60 | 32 to 88 | 0.63 | 0.38 to 1.00 |
| | | (2e) Needle stimulation (e.g., manual or electrical) | 13 | 87 | 67 to 100 | 0.74 | 0.50 to 0.99 |
| | | (2f) Needle retention time | 14 | 93 | 79 to 100 | 0.78 | 0.62 to 1.00 |
| | | (2 g)Needle type (diameter, length and manufacturer or material) | 10 | 67 | 40 to 94 | 0.70 | 0.53 to 1.00 |
| 3 | Treatment regimen | (3a) Number of treatment sessions | 10 | 67 | 40 to 94 | 0.62 | 0.33 to 0.98 |
| | | (3b) Frequency and duration of treatment sessions | 10 | 67 | 40 to 94 | 0.69 | 0.43 to 1.00 |
| 4 | Other components of treatment | (4a) Details of other interventions administered to the acupuncture group (e.g., moxibustion, cupping, herbs, exercises, lifestyle advice) | 3 | 20 | −3 to 43 | 0.85 | 0.68 to 0.99 |
| | | (4b) Setting and context of treatment, including instructions to practitioners, and information and explanations to patients | 5 | 33 | 6 to 60 | 0.64 | 0.35 to 0.98 |
| 5 | Practitioner background | (5) Description of participating acupuncturists (qualification or professional affiliation, years in acupuncture practice, other relevant experience) | 8 | 53 | 25 to 82 | 0.76 | 0.62 to 1.00 |
| 6 | Control or comparator interventions | (6a) Rationale for the control or comparator in the context of the research question, with sources that justify the choice(s) | 9 | 60 | 32 to 88 | 0.78 | 0.65 to 1.00 |
| (6b) Precise description of the control or comparator. If sham acupuncture or any other type of acupuncture-like control is used, provide details as for items 1–3 above | 9 | 60 | 32 to 88 | 0.73 | 0.56 to 1.00 |
Reporting quality of key methodological items (n = 15)
| 9 | Allocation concealment | Description of the method used to implement the random allocation sequence assuring the concealment until interventions are assigned | 5 | 33 | 6 to 60 | 0.68 | 0.45 to 1.00 |
| 11 | Blinding | Whether or not participants, those administering the interventions, or those assessing the outcomes were blinded to group assignment | 9 | 60 | 32 to 88 | 0.75 | 0.52 to 1.00 |
| 16 | Intent-to-treat analysis | No. of participants in each group included in each analysis and whether it was done by “intention to treat” | 5 | 33 | 6 to 60 | 0.82 | 0.68 to 1.00 |
Figure 1Diagram flow of the randomized controlled trials articles selection process.
Multivariate linear regression analysis for factors associated with better OQS from the CONSORT statement (n = 15)
| Constant | 2.32 | 2.59 | 0.90 | 0.39 | −3.28 ~ 7.92 |
| Funding source | 4.05 | 1.67 | 2.43 | 0.03 | 0.44 ~ 7.67 |
Univariate analysis for factors associated with better OQS from STRICTA (n = 15)
| Constant | −958.16 | 446.54 | −2.15 | 0.05 | −1922.84 ~ 6.53 |
| Year of publication | 0.48 | 0.22 | 2.17 | 0.05 | 0.00 ~ 0.96 |